| 1 |
34387609 | Circular RNA circ_0008450 regulates the proliferation, migration, invasion, apoptosis and chemosensitivity of CDDP-resistant nasopharyngeal carcinoma cells by the miR-338-3p/SMAD5 axis. | 2022 Jan 1 |
1 |
| 2 |
34593606 | A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1. | 2022 Jan |
1 |
| 3 |
34648915 | Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer. | 2022 Jan 30 |
2 |
| 4 |
34774850 | Flotillin-1 promotes progression and dampens chemosensitivity to cisplatin in gastric cancer via ERK and AKT signaling pathways. | 2022 Feb 5 |
1 |
| 5 |
34810212 | Deregulation of AKT-mTOR Signaling Contributes to Chemoradiation Resistance in Lung Squamous Cell Carcinoma. | 2022 Mar 1 |
4 |
| 6 |
34856444 | Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway. | 2022 Feb |
1 |
| 7 |
34982265 | OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway. | 2022 Jan 4 |
2 |
| 8 |
35001804 | Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway. | 2022 Jan |
1 |
| 9 |
35040385 | Inhibiting L1CAM Reverses Cisplatin Resistance of Triple Negative Breast Cancer Cells by Blocking AKT Signaling Pathway. | 2022 Apr |
4 |
| 10 |
35057550 | Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway. | 2022 Jan 15 |
1 |
| 11 |
35069879 | CRNDE silencing promotes apoptosis and enhances cisplatin sensitivity of colorectal carcinoma cells by inhibiting the Akt/mTORC1-mediated Warburg effect. | 2022 Feb |
2 |
| 12 |
35099408 | Stress hormone norepinephrine incites resistance of oral cancer cells to chemotherapy. | 2022 Mar 5 |
2 |
| 13 |
35118193 | lncRNA SNHG26 promoted the growth, metastasis, and cisplatin resistance of tongue squamous cell carcinoma through PGK1/Akt/mTOR signal pathway. | 2022 Mar 17 |
1 |
| 14 |
35125086 | Nimbolide, a Neem Limonoid, Inhibits Angiogenesis in Breast Cancer by Abrogating Aldose Reductase Mediated IGF-1/PI3K/Akt Signalling. | 2022 |
1 |
| 15 |
35152083 | Corrigendum to "MK2206 enhances cisplatin-induced cytotoxicity and apoptosis in testicular cancer through Akt signaling pathway inhibition" [Transl Oncol. 2020 Jul;13(7):100769]. | 2022 Apr |
1 |
| 16 |
35205603 | HPRT1 Promotes Chemoresistance in Oral Squamous Cell Carcinoma via Activating MMP1/PI3K/Akt Signaling Pathway. | 2022 Feb 9 |
2 |
| 17 |
35205706 | Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. | 2022 Feb 15 |
1 |
| 18 |
35209822 | MeCP2 Increases Cisplatin Resistance in Human Gastric Cancer through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription. | 2022 Feb 23 |
1 |
| 19 |
35214200 | Carboxyl-Functionalized Carbon Nanotubes Loaded with Cisplatin Promote the Inhibition of PI3K/Akt Pathway and Suppress the Migration of Breast Cancer Cells. | 2022 Feb 21 |
2 |
| 20 |
35219213 | Retraction notice to "G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway" [J. Reprod. Immunol. 140C (2020) 103129]. | 2022 Mar |
1 |
| 21 |
35238281 | BEZ235 reduction of cisplatin resistance on wild-type EGFR non-small cell lung cancer cells. | 2022 Mar 3 |
2 |
| 22 |
35256453 | Agmatine Alleviates Cisplatin-Induced Ototoxicity by Activating PI3K/AKT Signaling Pathway. | 2022 Mar-Apr |
3 |
| 23 |
35263216 | Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis. | 2022 Mar |
2 |
| 24 |
35291604 | PI3K Inhibition Sensitize the Cisplatin-resistant Human Ovarian Cancer Cell OVCAR3 by Induction of Oxidative Stress. | 2022 Jan |
7 |
| 25 |
35346788 | Menstrual blood-derived endometrial stem cells ameliorate the viability of ovarian granulosa cells injured by cisplatin through activating autophagy. | 2022 Jun |
1 |
| 26 |
35411640 | Far-infrared radiation alleviates cisplatin-induced vascular damage and impaired circulation via activation of HIF-1α. | 2022 Jun |
1 |
| 27 |
35517416 | Role of Integrin β1 in the progression and chemo-resistance of esophageal squamous cell carcinoma. | 2022 |
1 |
| 28 |
35530135 | Inhibiting DNA methylation alleviates cisplatin-induced hearing loss by decreasing oxidative stress-induced mitochondria-dependent apoptosis via the LRP1-PI3K/AKT pathway. | 2022 Mar |
1 |
| 29 |
35578316 | SCARA3 inhibits cell proliferation and EMT through AKT signaling pathway in lung cancer. | 2022 May 16 |
1 |
| 30 |
35585821 | Transcriptome profiling of cisplatin resistance in triple-negative breast cancer: New insight into the role of PI3k/Akt pathway. | 2022 May 17 |
1 |
| 31 |
35628594 | Nimodipine Treatment Protects Auditory Hair Cells from Cisplatin-Induced Cell Death Accompanied by Upregulation of LMO4. | 2022 May 21 |
1 |
| 32 |
32597316 | Investigation of EGFR/pi3k/Akt signaling pathway in seminomas. | 2021 Feb |
1 |
| 33 |
32730654 | Cancer-derived IgG involved in cisplatin resistance through PTP-BAS/Src/PDK1/AKT signaling pathway. | 2021 Apr |
4 |
| 34 |
33300085 | miR‑139‑5p enhances cisplatin sensitivity in non‑small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of Homeobox protein Hox‑B2. | 2021 Feb |
1 |
| 35 |
33434185 | CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis. | 2021 Feb 22 |
1 |
| 36 |
33515421 | Downregulation of HOXA11 enhances endometrial cancer malignancy and cisplatin resistance via activating PTEN/AKT signaling pathway. | 2021 Jul |
1 |
| 37 |
33557670 | T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways. | 2021 Dec |
1 |
| 38 |
33581579 | PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression. | 2021 May |
2 |
| 39 |
33617838 | Pentraxin 3 acts as a functional effector of Akt/NF-κB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer. | 2021 Apr 15 |
1 |
| 40 |
33644057 | Cisplatin-Resistant Gastric Cancer Cells Promote the Chemoresistance of Cisplatin-Sensitive Cells via the Exosomal RPS3-Mediated PI3K-Akt-Cofilin-1 Signaling Axis. | 2021 |
5 |
| 41 |
33714198 | MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling. | 2021 Mar 10 |
1 |
| 42 |
33717260 | The miR-136-5p/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells. | 2021 Apr |
1 |
| 43 |
33738259 | Heat Shock Protein 90 Triggers Multi-Drug Resistance of Ovarian Cancer via AKT/GSK3β/β-Catenin Signaling. | 2021 |
2 |
| 44 |
33749526 | PRDX1 activates autophagy via the PTEN-AKT signaling pathway to protect against cisplatin-induced spiral ganglion neuron damage. | 2021 Dec |
1 |
| 45 |
33760204 | miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling. | 2021 May |
1 |
| 46 |
33773191 | Bibenzyl analogue DS-1 inhibits MDM2-mediated p53 degradation and sensitizes apoptosis in lung cancer cells. | 2021 May |
1 |
| 47 |
33794187 | FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer. | 2021 Aug |
1 |
| 48 |
33813077 | Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma. | 2021 May 21 |
1 |
| 49 |
33816292 | Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway. | 2021 |
4 |
| 50 |
33850634 | lncRNA LOC102724169 plus cisplatin exhibit the synergistic anti-tumor effect in ovarian cancer with chronic stress. | 2021 Jun 4 |
1 |